Lenovo has revealed that it’ll soon launch a new variant of the Legion Y700 tablet with support for 5G networks and an OLED screen. The current model of the Y700 offers a Snapdragon 8 Elite Gen 5 ...

With Destiny 2's final update having dropped on June 9, there's a real 'last day of school' vibe around Bungie right now. That's going to work out really well for us, because even though a new bug ...

Race beyond the orange track and jump into a Hot Wheels-sized world with four islands to explore, each with its own vibe and challenges. Roam freely through a world full of adventures, smash obstacles ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Today's buzz is about Richard Dawkins and how he found consciousness in a large language model. There's enough in the press to satiate your imagination. But I think there's something deeper here to ...

We’ve all been there: your dinner guests are about to arrive, and your bookshelf is looking a little basic. Worrying that copies of I Hope They Serve Beer In Hell signed by Tucker Max don’t impress ...

Halo Infinite is really living up to its name. Six months after developer Halo Studios announced the end of Infinite's major content updates, the live-service shooter just got a brand-new mode out of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Najat Khan, CEO, opened by stating that Recursion is at an important inflection point, harnessing its integrated AI-driven platform to "translate insights into evidence; evidence that this platform, ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...